Black Diamond Therapeutics Inc
BDTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$104.86M
Close$
$6.39
267.4% upside
Current Fair Value
267.4% upsideUndervalued by 267.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $104.86 Million |
|---|---|
| Enterprise Value | $102.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.39 |
| Beta | 3.33 |
| Outstanding Shares | 57,367,283 |
Return
| Return on Equity | -44.29% |
|---|---|
| Return on Assets | -34.04% |
| Return on Invested Capital | -41.93% |
Valuation & Multiples
| P/E Ratio | -2.47 |
|---|---|
| PEG | 39.81 |
| Price to Sales | - |
| Price to Book Ratio | 1.74 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.24 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$8.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2359▼ 158.44% |
|---|---|
| Total Calls | 370,500▲ 559.25% |
| Total Puts | 87,400▼ 14.57% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 61.37%▼ 5.92% |
|---|---|
| Total Invested | $65.21M▼ 20.51% |
| Investors Holding | 103▼ 5.00% |
ESG Score
No data